CVS Caremark today issued a report that highlight research the company is conducting around medication adherence, including one study that reviews and compares state-by-state adherence rates for patients managing four chronic diseases. The State of the States: Adherence Report is a first-of-its kind study that looks at how patients in all 50 states are complying with their doctors’ orders about taking medication. The review of CVS Caremark’s pharmacy benefit management claims data focused on four common disease states – hypertension, high cholesterol, diabetes and depression – diseases that make up a large portion of pharmacy spend by health plan sponsors. Read more
CVS Caremark Publishes State of the States: Adherence Report
More from GeneralMore posts in General »
- Results From International Pilot Survey on Health Care Environmental Hygiene at Facility Level Highlights Need for Improvement
- Rates of Adverse Events in Hospitalized Patients After Summer-Time Resident Changeover in the United States: Is There a July Effect?
- HCCI Report Finds Birthing People in the U.S. Pay Nearly $2,000 Out-of-Pocket to Have a Baby
- Healthgrades Announces 2022 State Hospitals Rankings List
- Fraser Institute: Annual Comparison of International Health Care Systems